Park Ha Biological Technology Co., Ltd. (BYAH)
NASDAQ: BYAH · Real-Time Price · USD
1.080
-0.020 (-1.82%)
Apr 28, 2026, 4:00 PM EDT - Market closed

BYAH Income Statement

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Revenue
2.522.382.461.920.93
Revenue Growth (YoY)
6.00%-3.14%28.12%106.16%-
Cost of Revenue
0.140.20.310.510.31
Gross Profit
2.382.192.151.410.62
Selling, General & Admin
26.111.180.781.151.12
Research & Development
0.240.040.030.06-
Operating Expenses
26.531.390.971.211.12
Operating Income
-24.150.791.180.2-0.5
Interest Expense
-0---0-0
Interest & Investment Income
0.010000
Other Non Operating Income (Expenses)
0.06-0-0-0.010.02
Pretax Income
-24.080.791.180.19-0.48
Income Tax Expense
0.280.310.33-0-
Net Income
-24.360.480.850.19-0.48
Net Income to Common
-24.360.480.850.19-0.48
Net Income Growth
--43.83%345.40%--
Shares Outstanding (Basic)
11111
Shares Outstanding (Diluted)
11111
Shares Change (YoY)
17.77%----
EPS (Basic)
-41.380.961.700.38-0.97
EPS (Diluted)
-41.380.961.700.38-1.00
EPS Growth
--43.83%345.40%--
Free Cash Flow
-00.870.11.43-0.51
Free Cash Flow Per Share
-0.011.750.212.86-1.02
Gross Margin
94.36%91.80%87.35%73.47%66.58%
Operating Margin
-956.45%33.32%48.01%10.27%-53.81%
Profit Margin
-965.00%20.09%34.65%9.97%-52.09%
Free Cash Flow Margin
-0.12%36.73%4.22%74.52%-54.86%
EBITDA
-24.040.821.20.23-0.46
EBITDA Margin
-34.28%48.82%11.85%-49.62%
D&A For EBITDA
0.110.020.020.030.04
EBIT
-24.150.791.180.2-0.5
EBIT Margin
-33.32%48.01%10.27%-53.81%
Effective Tax Rate
-39.68%27.89%--
Advertising Expenses
0.020--0.04
Source: S&P Capital IQ. Standard template. Financial Sources.